Pharmacotherapy Specialty Core Therapeutic Module Package for Recertification (Cert # L199335)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 10/23/2019
Content Release Date: 11/20/2019
Expiration Date: 11/17/2020
Activity Type: Application-based
CE Credits: 5.0 hours (BPS and ACPE)
Activity Fee: $100 (ASHP member); $150 (non-member) 

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

These activities are intended for Board Certified Pharmacotherapy Specialists in need of recertification credit.

Activity Overview

The Core Therapeutic Modules for Recertification Package consists of 5 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

Each activity is approved for 1.0 hour of continuing pharmacy education credit. Successful completion of all the learning modules will provide up to 5.0 hours of continuing pharmacy education credit.

Recertification Credit*

Board certified pharmacists are eligible to receive 5.0 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed.

These activities are part of the ASHP professional development program for BCPS recertification approved by the BPS. 

ACPE Number

Learning Module

Credit Hours

*Assessment Pass Point

0204-0000-19-615-H01-P

Select Topics in Infectious Diseases: Part 1

1

75%

0204-0000-19-616-H01-P

Select Topics in Infectious Diseases: Part 2

1

0204-0000-19-602-H01-P

Fluid, Electrolytes, and Nutrition

1

0204-0000-19-617-H01-P

Select Topics in Neurologic Disorders

1

0204-0000-19-618-H01-P

Diabetes

1

 

Learning Objectives

Select Topics in Infectious Diseases: Part 1

ACPE number: 0204-0000-19-615-H01-P

For the following diseases: C. Difficile infection, skin and soft tissue infections, upper respiratory tract infections, community acquired pneumonia

  • Interpret laboratory and diagnostic tests.
  • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
  • Manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment.
Select Topics in Infectious Diseases: Part 2

ACPE number: 0204-0000-19-616-H01-P

For the following diseases: sexually transmitted diseases, urinary tract infections, endocarditis, meningitis

  • Interpret laboratory and diagnostic tests.
  • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
  • Manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment.
Fluid, Electrolytes, and Nutrition

ACPE number: 0204-0000-19-602-H01-P

Interpret laboratory and diagnostic tests to evaluate fluid, electrolyte and nutrition status.

  • Select the appropriate route for nutrition administration, and evaluate if nutrition needs are being met based on patient-specific information and current guidelines.
  • Manage drug-related electrolyte interactions and nutrient interactions.
  • Determine the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines.
Select Topics in Neurologic Disorders

ACPE number: 0204-0000-19-617-H01-P

For patients with seizure disorders, Parkinson's Disease, migraine and sleep disorders:

  • Evaluate the risks and benefits of drug therapy considering other medication and patient specific factors.
  • Formulate the most appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines.
  • Manage drug-related problems and evaluate response to therapy.
Diabetes

ACPE number: 0204-0000-19-618-H01-P

  • Interpret diagnostic and/or laboratory tests in patients with diabetes.
  • Formulate the most appropriate treatment and monitoring plans, based on patient-specific information and current guidelines for patients with diabetes.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow-up assessment in patients with diabetes.

Planners, Presenters, and Reviewers 

Full Faculty Bios

Angela L. Bingham, Pharm.D., BCPS, BCNSP, BCCCP*
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy at University of the Sciences
Philadelphia, Pennsylvania
Clinical Pharmacy Specialist
Cooper University Hospital
Camden, New Jersey
Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP*
Professor, Department of Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center
Louisville, Kentucky
Snehal Bhatt, Pharm.D., BCPS*
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Science
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Lourdes Cross, BCPS
Assistant Professor
Sullivan University College of Pharmacy
Louisville, Kentucky 
Karrie Derenski, Pharm.D., BCNSP, BCCCP, CNSC
Pharmacy & Metabolic Support Supervisor
Cox Health
Springfield, Missouri
Brian Hoff, BCPS
Infectious Diseases Clinical Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois
Professor and Infectious Diseases Clinical Specialist
West Virginia University (WVU) and WVU Hospitals and Clinics
Canonsburg, Pennsylvania/div>
Trent Towne, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
College of Pharmacy, Natural and Health Sciences
Manchester University
Fort Wayne, IN
Jon Wietholter, Pharm.D., BCPS
Clinical Associate Professor
West Virginia University School of Pharmacy
Morgantown, WV
*Content Matter Experts

Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.
Susan R. Dombrowski, M.S., R.Ph.

Kristen Bossert, Pharm.D., BCPS
Mary Dimaano, Pharm.D., BCPS
Michelle Fraley, Pharm.D., BCPS
Kisha Gant, Pharm.D., BCACP, BCGP, BCPS
Michael German, Pharm.D., BCPS
Nicole Humbert, Pharm.D., BCPS
Jeffrey Larsen, Pharm.D., BCPS
Melanie Madorsky, Pharm.D., BCPS, BCCP
Marisa Strychalski, Pharm.D., BCPS, BCACP
Linsey Thompson, Pharm.D., BCPS

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

Christopher Betz: Advisory Board, Portola Pharmaceuticals; Speaker Bureau, Janssen Pharmaceuticals, Inc.

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

These activities were developed by ASHP.